Description: Biotage AB (publ), a life science company, provides separation technologies in the areas of organic and analytical chemistry, biomolecules, as well as for industrial scale up applications. It offers sample preparation solutions; horizon food and environmental products; microwave synthesis solutions; peptide synthesis and purification solutions; flash purification products; work-up products; evaporation and concentration solutions; and industrial and large scale products, such as flash purification, metal scavenging, reagents and scavengers, and custom resins. The company sells its products to pharmaceutical and biotechnical companies, contract research and manufacturing organizations, government authorities, and academic institutions; and commercial labs, hospital, CROs, bio-analytical laboratories, food manufacturers, and labs performing for food safety and environmental analysis. It operates in North and South America, Europe, Japan, China, South Korea, India, the Middle East, Africa, and Asia Pacific. The company was founded in 1969 and is headquartered in Uppsala, Sweden.
Home Page: www.biotage.com
Box 8
Uppsala,
751 03
Sweden
Phone:
46 18 56 59 00
Officers
| Name | Title |
|---|---|
| Mr. Tomas Blomquist | CEO & Pres |
| Ms. Maja Nilsson | Chief Financial Officer |
| Mr. Anders Wikstrom BSc, CS | Exec. VP of Operations |
| Dr. Jon-Sverre Schanche Ph.D. | Chief Scientific Officer |
| Mr. Lars Backman LLB | Chief Legal Officer |
| Raffaella Bombarda | EVP of Global Marketing |
| Ms. Petra Duprez | Chief HR & Sustainability Officer |
| Mr. Scott Carr | Pres of Americas & Chief/Head of Americas |
| Mr. Jonas Stahlberg | Chief Auditor |
| Mr. Olof Nord | Exec. VP of Bus. Devel. |
Exchange: OTCGREY
Country: US
Currency: US Dollar ($)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 50 |
| Price-to-Book MRQ: | 6.3572 |
| Price-to-Sales TTM: | 6.6125 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 510 |